Pazopanib: a promising new agent in the treatment of soft tissue sarcomas
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pazopanib: a promising new agent in the treatment of soft tissue sarcomas
Authors
Keywords
-
Journal
Future Oncology
Volume 7, Issue 12, Pages 1373-1383
Publisher
Future Medicine Ltd
Online
2011-11-23
DOI
10.2217/fon.11.116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pazopanib for the treatment of renal cancer
- (2011) Brian Rini et al. EXPERT OPINION ON PHARMACOTHERAPY
- Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years
- (2010) N. Penel et al. ANNALS OF ONCOLOGY
- Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism
- (2010) C-F Xu et al. BRITISH JOURNAL OF CANCER
- Pazopanib: a multikinase inhibitor with activity in advanced renal cell carcinoma
- (2010) Ronald M Bukowski Expert Review of Anticancer Therapy
- Comparison of Two Doses of Imatinib for the Treatment of Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Meta-Analysis of 1,640 Patients
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
- (2010) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma
- (2010) Chun-Fang Xu et al. JOURNAL OF HEPATOLOGY
- (Pre-)Clinical Pharmacology and Activity of Pazopanib, a Novel Multikinase Angiogenesis Inhibitor
- (2010) P. Hamberg et al. ONCOLOGIST
- Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
- (2009) Kristy J. Gotink et al. ANGIOGENESIS
- Phase I Trial of Pazopanib in Patients with Advanced Cancer
- (2009) H. I. Hurwitz et al. CLINICAL CANCER RESEARCH
- New medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma
- (2009) Thomas Schmitt et al. Expert Review of Anticancer Therapy
- Absence of Progression As Assessed by Response Evaluation Criteria in Solid Tumors Predicts Survival in Advanced GI Stromal Tumors Treated With Imatinib Mesylate: The Intergroup EORTC-ISG-AGITG Phase III Trial
- (2009) Axel Le Cesne et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
- (2009) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group
- (2008) M. Schlemmer et al. EUROPEAN JOURNAL OF CANCER
- Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor†
- (2008) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now